Highbridge Capital Management LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Highbridge Capital Management LLC

  • $333 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $505,312 - $630,048
-1,600 Reduced 61.54%
1,000 $342,000
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $1 Million - $1.32 Million
-2,800 Reduced 51.85%
2,600 $979,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $2.33 Million - $2.72 Million
5,400
5,400 $2.41 Million

Others Institutions Holding REGN

# of Institutions
1,500
Shares Held
83M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email